News
Read the latest news about audiology and hearing aid systems.
Tinnitus UK Rates Lenire as Most Effective Treatment Option
November 5, 2025
Lenire by Neuromod is now the highest rated available tinnitus treatment option for safety and effectiveness Read More
Industry
Neuromod Launches Online Tinnitus Masterclass
October 21, 2025
Neuromod has launched Tinnitus Masterclass, an online course that provides hearing care professionals with expert clinical and commercial knowledge to introduce effective and sustainable tinnitus care... Read More
Industry
Neuromod Advance Multiple Regulatory Approvals to Expedite Global Availability of Lenire
September 23, 2025
Lenire made regulatory history in 2023 by becoming the first and only FDA-approved bimodal neuromodulation tinnitus treatment device. Read More
Industry
Neuromod Expands Availability of Lenire Tinnitus Treatment Device in Europe with 19 New Clinical Partnerships
September 16, 2025
Neuromod Devices announced 19 new clinical partnerships to expand the availability of the Lenire tinnitus treatment device in Europe. Read More
Industry
Nature Communications Medicine Publishes Positive, Real World Data for Tinnitus Patients Treated with Unique, FDA Approved Stimulation Device
April 28, 2025
Nature Communications Medicine has published the first peer reviewed, real-world analysis of U.S. patients treated with Lenire, the only FDA approved tinnitus treatment device of its kind. Read More
Industry
Lenire Supports Veterans by Sponsoring Hearoes Tour
April 7, 2025
Lenire proudly sponsors the 10th Annual LexCare Hearing Foundation Hearoes Tour. Lenire is a treatment option for 3.2m veterans living with tinnitus. Read More
Industry
Neuromod Closes €10 Million Financing to Accelerate Commercialization
March 11, 2025
Neuromod Devices Ltd. (Neuromod), an Irish medical device company specialising in tinnitus, has successfully closed a €10 million equity financing to expand the availability of its tinnitus treatmen... Read More
Industry
UK Clinics Providing Lenire Tinnitus Treatment Device Double in Latest Expansion
February 11, 2025
Neuromod Devices, the medical device company that specialises in tinnitus treatment, has announced they are partnering with 4 UK clinics to expand the availability of Lenire®, the clinically proven t... Read More
Industry
Real World Data Supports Lenire Tinnitus Treatment Effectiveness Shown in Large-Scale Clinical Trials
September 4, 2024
The first real-world analysis of tinnitus patients treated with Lenire in the United States has been submitted to a journal for peer-review and is now available on an online pre-print server for healt... Read More
Industry
Neuromod Partners with 14 New US Tinnitus Clinics to Expand Availability of FDA Approved Lenire
June 27, 2024
The number of practice partners providing Lenire across the USA has increased to more than 80 in Lenire’s second US expansion of 2024.Lenire will be expanding the number of clinics in California... Read More
Industry
FDA-Approved Lenire Tinnitus Device Now a Treatment Option for 2.9 Million US Veterans Through Veterans Affairs
June 17, 2024
Neuromod USA Inc. has been awarded a Federal Supply Schedule 65 II Medical Equipment and Supply Contract from the US Government Read More
Industry
Breakthrough Tinnitus Treatment Device Lenire Expands Clinics in Spain
April 5, 2024
The breakthrough tinnitus treatment device, Lenire, is now available in four clinics in Spain – Barcelona, Malaga, Seville, and Granada. In Lenire’s second clinical trial, TENT-A2, 91% of patients... Read More
Associations
FDA Approved Lenire Expands Number of US Clinics
February 29, 2024
Neuromod Devices, the medical technology company that developed tinnitus treatment device, Lenire, has partnered with an additional 24 new US clinics to address the significant demand for the FDA-appr... Read More
Industry
Lenire Now Available in Monaco Through Otoneuro
February 22, 2024
Neuromod Devices, the medical technology business behind tinnitus treatment device, Lenire, has partnered with state-of-the-art hearing and balance centre, Otoneuro, to make Lenire available in Monaco... Read More
Industry
Neuromod Expands Lenire’s US Availability to More Than 50 Providers
October 10, 2023
Neuromod Devices has completed the training and onboarding of additional healthcare professionals in the USA to treat tinnitus patients with Lenire, its bimodal neuromodulation device. Read More
Neuromod Devices Closes €30 Million Financing to Expand Availability of Tinnitus Treatment Device Lenire®
April 13, 2023
Neuromod Devices Ltd, an Irish medical device company specialising in neuromodulation, has successfully closed a €30 million financing to further commercialise its tinnitus treatment device, Lenire. Read More
Industry
FDA Grants Lenire® Tinnitus Treatment Device De Novo Approval
March 7, 2023
Neuromod Devices Ltd. announced today that the US Food and Drug Administration (FDA) has granted De Novo approval to Lenire, the first bimodal neuromodulation device of its kind to be approved by the... Read More
Neuromod Publishes Results of Second Large Scale Clinical Trial for Tinnitus in Top-Tier Scientific Journal, Shows Greater Improvement of Symptoms
June 30, 2022
Neuromod Devices Limited has published the results of the company’s TENT-A2 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A2) clinical trial in the highly regarded scientific journ... Read More
Industry
Lenire®, the Treatment Device Shown to Reduce Tinnitus Symptoms in 86.2% Of Patients, Is Now Available in Norway
May 20, 2022
Lenire®, the treatment device shown to reduce tinnitus symptoms in 86.2% of patients, is now available in Norway. Read More
Industry
Neuromod Establishes Global Commercial Leadership Team
April 7, 2022
Neuromod Devices Ltd. has announced the formation of a global commercial leadership team to direct the commercialization of its Lenire tinnitus treatment device through key partnerships. Read More
Industry
